Follow Us on StockTwits

Alliqua BioMedical Gets FDA Marketing Approval For Ultrasound Wound Care System

Posted by on December 27, 2016 7:40 AM
Tags: , ,
Categories: Stocks

December 27, 2016: Alliqua BioMedical has exploded higher on FDA marketing approval for an ultrasound wound care system. The FDA 510K clearance decision date is noted as 12/22. Source:

November 8, 2016: Rodman & Renshaw/ H.C. Wainwright reiterates a Buy rating on Alliqua BioMedical and sets a price target of $2.50.

Alliqua BioMedical Stock Chart

Alliqua is a provider of advanced wound care solutions.

Follow me

Lance Jepsen

For ethical purposes, I try not to hold any position in any stock I profile on unless specifically stated in the article. Owner of Seasoned entrepreneur, investor, and writer. I love God, family, country, stock trading, economics, and helping people learn how to trade.
Follow me